Previous close | 12.74 |
Open | 13.39 |
Bid | 14.13 x 500 |
Ask | 14.21 x 800 |
Day's range | 12.17 - 14.21 |
52-week range | 10.87 - 83.60 |
Volume | |
Avg. volume | 1,289,957 |
Market cap | 1.527B |
Beta (5Y monthly) | 0.43 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Comprehensive Analysis of NovoCure's First Quarter Financial Performance
NovoCure (NVCR) delivered earnings and revenue surprises of 16.28% and 5.30%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
NovoCure (NVCR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.